Evidence map›Paper›PMID 35122004›Full record

ArticleNature cancer2020

Securing the future of the clinician-scientist.

Karen Noble, Joanna Owens, Fabrice André, Samuel F Bakhoum, Sherene Loi, Hans Christian Reinhardt, David Tuveson, Charles Swanton

Abstract read
PubMed Publisher
In one paragraph

Article in Nature cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Training and Retaining Physician‒Scientists in Dermatology: The German Perspective.JID innovations : skin science from molecules to population health · 2022
    Article
  16. Article
  17. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Karen NobleResearch Funding, Cancer Research UK, London, UK.
Joanna OwensFaraday Science Communications, Basingstoke, UK.
Fabrice AndréDepartment of Medical Oncology, Gustave Roussy Cancer Centre, Université Paris Saclay , Villejuif, France.
Samuel F BakhoumHuman Oncology and Pathogenesis Program, Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Sherene LoiTranslational Breast Cancer Genomics and Therapeutics Laboratory, Peter McCallum Cancer Centre, Melbourne, Australia.
Hans Christian ReinhardtDepartment of Internal Medicine, University of Cologne, Cologne, Germany.
David TuvesonCold Spring Harbor Laboratory, New York, NY, USA.
Charles SwantonResearch Funding, Cancer Research UK, London, UK. charles.swanton@crick.ac.uk.ORCID http://orcid.org/0000-0002-4299-3018

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

PhysiciansHumansResearch Personnel

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.